共 30 条
- [28] Final Analysis of the Phase 4 KEYNOTE-B10 Study: First-Line(1L) Pembrolizumab (pembro) plus Carboplatin (carbo) plus Paclitaxel (pacli) for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E3 - E4
- [29] Comparative Efficacy of KEYNOTE-B10 Regimen as First-Line (1L) Therapy in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): A Network Meta-Analysis (NMA) with Aggregate-Level Matching INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : E32 - E33